(Q71653928)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7524508%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7524508%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

Long‐term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue diseases (English)

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

17 May 2024

1 reference

pulmonary hypertension

1 reference

4

J. J. Gomez-Reino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7524508

17 May 2024

author name string

J. de la Mata

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7524508

17 May 2024

M. A. Gomez-Sanchez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7524508

17 May 2024

M. Aranzana

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7524508

17 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7524508

17 May 2024

publication date

1 October 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7524508%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

20 October 2019

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/art.1780371018

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7524508

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fart.1780371018

17 May 2024

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.1780371018

17 May 2024

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

17 May 2024

published in

Arthritis and Rheumatism

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7524508%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7524508%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7524508%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

1528-1533

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7524508%20AND%20SRC:MED&resulttype=core&format=json

Primary pulmonary hypertension

20 October 2019

cites work

2

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Primary pulmonary hypertension: natural history and the importance of thrombosis

17 May 2024

3

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

17 May 2024

4

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Antinuclear antibodies in primary pulmonary hypertension

17 May 2024

5

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Lung biopsy specimens in the evaluation of pulmonary vascular disease

17 May 2024

6

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension

17 May 2024

8

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry

17 May 2024

9

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

17 May 2024

10

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Endothelial dysfunction in pulmonary hypertension

17 May 2024

11

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Pulmonary vascular changes in scleroderma

17 May 2024

12

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma)

17 May 2024

13

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis

17 May 2024

14

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.

17 May 2024

15

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Abnormalities of pulmonary vascular dynamics and inflammation in early progressive systemic sclerosis

17 May 2024

18

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Vascular reactivity and pulmonary hypertension in systemic sclerosis

17 May 2024

19

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Pulmonary vascular response during Raynaud's phenomenon in progressive systemic sclerosis.

17 May 2024

20

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Nifedipine and prazosin in the management of pulmonary hypertension in CREST syndrome

17 May 2024

21

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Nifedipine treatment for pulmonary hypertension in a patient with systemic sclerosis

17 May 2024

22

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Transient effect of nifedipine on pulmonary hypertension of systemic sclerosis.

17 May 2024

23

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

17 May 2024

26

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

17 May 2024

27

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

17 May 2024

28

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin)

17 May 2024

29

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial

17 May 2024

30

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Prostacyclin-induced acute pulmonary vasodilation in primary pulmonary hypertension

17 May 2024

31

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

The place of prostacyclin in the clinical management of primary pulmonary hypertension

17 May 2024

32

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Hemodynamic effects of iloprost, a prostacyclin analog

17 May 2024

34

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Different Hemodynamic Responses between Acute and Chronic Infusion of Iloprost (Prostacyclin-stable Analogue) in Severe Pulmonary Hypertension

17 May 2024

35

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

17 May 2024

37

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Cardiovascular manifestations of mixed connective tissue disease in adults.

17 May 2024

39

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Pulmonary hypertension in connective tissue disease. Clinical analysis of sixty patients in multi-institutional study

17 May 2024

40

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Mixed connective tissue disease with fatal pulmonary hypertension and a review of literature

17 May 2024

41

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Pulmonary hypertension in systemic lupus erythematosus.

17 May 2024

42

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Pulmonary hypertension secondary to serum hyperviscosity in a patient with rheumatoid arthritis

17 May 2024

43

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Pulmonary hypertension in dermatomyositis

17 May 2024

44

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma

17 May 2024

45

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Failure of vasodilator infusion to alter pulmonary diffusing capacity in systemic sclerosis

17 May 2024

46

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation

17 May 2024

47

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Inhibition of protein C activation by endothelial cells in the presence of lupus anticoagulant

17 May 2024

50

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Treatment for primary pulmonary hypertension. Back to the future

17 May 2024

52

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

Is it ethical to administer vasodilator drugs to patients with primary pulmonary hypertension?

17 May 2024

53

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

How should we judge the efficacy of drug therapy in patients with chronic congestive heart failure? The insights of six blind men

17 May 2024

54

1 reference

https://api.crossref.org/works/10.1002/ART.1780371018

17 May 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7524508%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference